MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD

Tanya Tacheva (Stara Zagora, Bulgaria), Tanya Tacheva, Dimo Dimov, Pavlina Chelenkova, Rumena Petkova, Krasimir Dimov, Stoyan Chakarov, Tatyana Vlaykova

Source: International Congress 2015 – Translational research in respiratory care: new findings
Session: Translational research in respiratory care: new findings
Session type: Thematic Poster Session
Number: 861
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tanya Tacheva (Stara Zagora, Bulgaria), Tanya Tacheva, Dimo Dimov, Pavlina Chelenkova, Rumena Petkova, Krasimir Dimov, Stoyan Chakarov, Tatyana Vlaykova. MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD. Eur Respir J 2015; 46: Suppl. 59, 861

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
MMP-3 serum levels and MMP3 -1171insA promoter polymorphism in patients with COPD
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


Plasma levels of TIPM-2 in patients with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016


Impact of -1562 C/T polymorphism of MMP9 gene on COPD susceptibility in Polish patients.
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014

-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


MTHFR 677C>T polymorphism in patients with COPD
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015


MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015


Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

Relationship between gene polymorphism in FGF10 and susceptibility to 220 patients with COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014

Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016


Associations of an intron MMP9 polymorphism and the serum levels of gelatinase B with the development of COPD
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019


Changes in the populations of blood T-lymphocytes containing chemokine receptors in non-smoking patients with COPD
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013


Investigating tensin1 expression and the presence of SNP identified in GWAS in COPD
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome
Source: International Congress 2015 – COPD: notable points
Year: 2015


Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



The role of genetic polymorphisms of glutation-S-transferase μ1 (GSTM1) and gelatinase B (MMP9) in the risk of COPD development
Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD
Year: 2003


Genes affecting mRNA stability and metalloproteinase inhibitor RECK are down-regulated in patients with COPD
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013



Variants of apelin gene and COPD
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016

Association of angiopoietin-like protein 4 with cardiovascular function in patients with COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016

Clara cells protein 16 (CC-16) level correlates with hemoglobin level in COPD patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013